About this Journal Submit a Manuscript Table of Contents
Journal of Thyroid Research
Volume 2012 (2012), Article ID 481568, 8 pages
http://dx.doi.org/10.1155/2012/481568
Research Article

Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer

1Division of Endocrinology, Hospital de Clínicas, University of Buenos Aires, Córdoba 2351, 5th Floor, Buenos Aires 1424, Argentina
2Division of Medical Editing, Spencer-Fontayne Corporation, 33 Bentley Avenue, Jersey City, NJ 07304-1901, USA
3Division of Endocrinology, Hospital Churruca Visca, Uspallata 3400, Buenos Aires 1437, Argentina
4Division of Endocrinology, Consultorios Integrados Rosario, Italia 424, Santa Fe, Rosario 2000, Argentina

Received 16 August 2012; Accepted 17 October 2012

Academic Editor: Daniele Barbaro

Copyright © 2012 Fabián Pitoia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Fabi_n Pitoia, Robert J. Marlowe, Erika Abelleira, et al., “Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer,” Journal of Thyroid Research, vol. 2012, Article ID 481568, 8 pages, 2012. doi:10.1155/2012/481568